InfuSystem Holdings, Inc. (INFU)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 114% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- ROE of 11.2% — below-average profitability
- Revenue growing at 6% annually
InfuSystem Holdings, Inc. (INFU) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the AMEX , with a market capitalisation of $194 million . Key value metrics: P/E ratio 30.4, P/B ratio 3.39, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
InfuSystem Holdings, Inc. — Fundamental Analysis Summary
InfuSystem Holdings, Inc. (INFU) is currently trading 114% above its Graham Number of $4.49, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 30.4x.
On financial health, INFU shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 11.2% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.34.
StockPik's composite Value Score for INFU is 78/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
INFU reports a solid gross margin of 55.4% (sector average: 33.5%) and a modest operating margin of 8.0%.
INFU shows revenue growing at 6% year-over-year, with earnings growing at 183%.